45 results
8-K
EX-99.1
IBRX
ImmunityBio Inc
23 Apr 24
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class
6:17am
and previously presented.
The co-authors of an expert commentary on the published findings for ANKTIVA plus BCG in European Urology–Drs. Peter Black, Jonathan
424B5
uivkvc
24 Jul 23
Prospectus supplement for primary offering
5:12pm
8-K
EX-4.1
mgypwvijm1x8u9o26u
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-4.1
bh90cu1s en9lqwjcua
12 Dec 22
ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor
9:07am
424B5
lu5i5lhe8q0zk6tpbe
12 Dec 22
Prospectus supplement for primary offering
8:08am